Minerva Neurosciences Inc (NERV)
2.36
-0.05
(-2.07%)
USD |
NASDAQ |
Apr 30, 13:35
Minerva Neurosciences Stock Buybacks (Quarterly): -20.00M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -20.00M |
September 30, 2023 | 20.00M |
June 30, 2023 | -20.00M |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | |
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | -7.372M |
June 30, 2020 | -5.178M |
March 31, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 |
Date | Value |
---|---|
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 0.00 |
September 30, 2017 | -44.56M |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | -57.50M |
March 31, 2016 | -1.00M |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | -31.00M |
December 31, 2014 | 0.00 |
September 30, 2014 | -55.04M |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | -1.85M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-20.00M
Minimum
Jun 2023
20.00M
Maximum
Sep 2023
-2.959M
Average
--
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
Viking Therapeutics Inc | -597.12M |
Janux Therapeutics Inc | 0.00 |
ACADIA Pharmaceuticals Inc | -5.434M |
Karyopharm Therapeutics Inc | 0.00 |
Calidi Biotherapeutics Inc | -- |